Signature Devices, Inc. (SDVI)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Operating Revenue	-	0.01	0.44	0.37	0.14	0
Revenue	-	0.01	0.44	0.37	0.14	0
Revenue Growth (YoY)	-	-97.28%	17.26%	165.29%	3632.86%	-99.06%
Cost of Revenue	-	0.43	0.14	0.31	0.06	-
Gross Profit	-	-0.42	0.29	0.07	0.08	0
Selling, General & Admin	-	-	0.23	0.03	0.06	0.01
Research & Development	-	-	-	-	0.04	-
Other Operating Expenses	0	0	0.05	0	-	-
Operating Expenses	0.24	0.24	0.53	0.03	0.1	0.01
Operating Income	-0.24	-0.66	-0.23	0.03	-0.02	-0
Other Non Operating Income (Expenses)	-0.02	-0.01	-0.04	-0.02	0	-
EBT Excluding Unusual Items	-0.26	-0.68	-0.27	0.01	-0.02	-0
Other Unusual Items	-	-	0.82	-	-	-
Pretax Income	-0.26	-0.68	0.55	0.01	-0.02	-0
Net Income	-0.26	-0.68	0.55	0.01	-0.02	-0
Net Income to Common	-0.26	-0.68	0.55	0.01	-0.02	-0
Net Income Growth	-	-	3728.59%	-	-	-
Shares Outstanding (Basic)	6,147	5,647	3,902	3,053	3,053	-
Shares Outstanding (Diluted)	6,147	5,647	3,902	3,053	3,053	-
Shares Change (YoY)	43.32%	44.70%	27.82%	-	-	-
EPS (Basic)	-0.00	-0.00	0.00	0.00	-0.00	-
EPS (Diluted)	-0.00	-0.00	0.00	0.00	-0.00	-
EPS Growth	-	-	3425.00%	-	-	-
Free Cash Flow	-0.02	-0.02	-0.05	-0.41	0	0
Gross Margin	-	-	67.45%	17.63%	59.05%	100.00%
Operating Margin	-	-5587.39%	-53.64%	8.99%	-12.46%	-104.50%
Profit Margin	-	-5703.02%	126.78%	3.88%	-12.43%	-104.50%
Free Cash Flow Margin	-	-166.81%	-11.58%	-111.16%	1.16%	9.55%
EBITDA	-0	-0.43	-0.11	0.04	-0.01	-
EBITDA Margin	-	-	-25.97%	9.92%	-9.98%	-
D&A For EBITDA	0.24	0.23	0.12	0	0	-
EBIT	-0.24	-0.66	-0.23	0.03	-0.02	-0
EBIT Margin	-	-	-53.64%	8.99%	-12.46%	-104.50%
Advertising Expenses	-	-	0.09	0.01	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.